APA

Mul D., Wu S., de Paus R. A., Oostdijk W., Lankester A. C., Duyvenvoorde H. A. v., Ruivenkamp C. A. L., Losekoot M., Tol M. J. D. v., De Luca F., van de Vosse E. & Wit J. M. (20120524). A mosaic de novo duplication of 17q21-25 is associated with GH insensitivity, disturbed in vitro CD28-mediated signaling, and decreased STAT5B, PI3K, and NF-κB activation. : European journal of endocrinology.

Chicago

Mul D, Wu S, de Paus R A, Oostdijk W, Lankester A C, Duyvenvoorde H A van, Ruivenkamp C A L, Losekoot M, Tol M J D van, De Luca F, van de Vosse E and Wit J M. 20120524. A mosaic de novo duplication of 17q21-25 is associated with GH insensitivity, disturbed in vitro CD28-mediated signaling, and decreased STAT5B, PI3K, and NF-κB activation. : European journal of endocrinology.

Harvard

Mul D., Wu S., de Paus R. A., Oostdijk W., Lankester A. C., Duyvenvoorde H. A. v., Ruivenkamp C. A. L., Losekoot M., Tol M. J. D. v., De Luca F., van de Vosse E. and Wit J. M. (20120524). A mosaic de novo duplication of 17q21-25 is associated with GH insensitivity, disturbed in vitro CD28-mediated signaling, and decreased STAT5B, PI3K, and NF-κB activation. : European journal of endocrinology.

MLA

Mul D, Wu S, de Paus R A, Oostdijk W, Lankester A C, Duyvenvoorde H A van, Ruivenkamp C A L, Losekoot M, Tol M J D van, De Luca F, van de Vosse E and Wit J M. A mosaic de novo duplication of 17q21-25 is associated with GH insensitivity, disturbed in vitro CD28-mediated signaling, and decreased STAT5B, PI3K, and NF-κB activation. : European journal of endocrinology. 20120524.